Does neurokinin-1-receptor antagonist aprepitant diminish the efficacy of cyclophosphamide-based chemotherapy?: [letter to the editor]

Paiva, Carlos Eduardo; Paiva, Bianca Sakamoto Ribeiro; Michelin, Odair Carlito

Does neurokinin-1-receptor antagonist aprepitant diminish the efficacy of cyclophosphamide-based chemotherapy?: [letter to the editor] / O antagonista do receptor de neuroquinina-1 aprepitante diminui a eficácia da quimioterapia baseada em ciclofosfamida?: [carta ao editor]

Paiva, Carlos Eduardo; Paiva, Bianca Sakamoto Ribeiro; Michelin, Odair Carlito.

Affiliation

Paiva, Carlos Eduardo; Universidade Estadual Paulista. Oncological and Hemato-Oncological Center. Botucatu. BR
Paiva, Bianca Sakamoto Ribeiro; Universidade Estadual Paulista. Botucatu Medical School. Department of Nursing. Botucatu. BR
Michelin, Odair Carlito; Universidade Estadual Paulista. Botucatu Medical School. Department of Clinics. Botucatu. BR

São Paulo med. j ; 127(6): 385-386, Nov. 2009.

Article ي En | LILACS | ID: lil-547349

المكتبة المسؤولة: BR1.1

الموضوعات

النص الكامل

أضف إلى مجموعتك

طباعة

XML

Search on Google

النص الكامل: 1 الفهرس: LILACS الموضوع الرئيسي: Morpholines / Receptors, Neurokinin-1 / Antineoplastic Agents, Alkylating / Cyclophosphamide / Antiemetics المحددات: Female / Humans اللغة: En مجلة: São Paulo med. j موضوع المجلة: Cirurgia Geral / Cincia / Ginecologia / MEDICINA / Medicina Interna / Obstetr¡cia / Pediatria / Sa£de Mental / Sa£de P£blica السنة: 2009 نوع: Article

النص الكامل

أضف إلى مجموعتك

طباعة

XML

Search on Google